The anticancer drug ellipticine acts as an inducer of cytochromes P450 1A1/2 and potentiates its own pharmacological efficiency
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F03%3A00000565" target="_blank" >RIV/00216208:11310/03:00000565 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
The anticancer drug ellipticine acts as an inducer of cytochromes P450 1A1/2 and potentiates its own pharmacological efficiency
Original language description
The anticancer drug ellipticine induces CYP1A1/2 enzymes in rats of both sexes and influences uts own CYP-dependent metabolism and activation.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA203%2F01%2F0996" target="_blank" >GA203/01/0996: Study of molecular mechanism of anticancer effect of a chemotherapeutic, ellipticine</a><br>
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2003
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Chemické listy
ISSN
0009-2770
e-ISSN
—
Volume of the periodical
97
Issue of the periodical within the volume
S
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
1
Pages from-to
146-146
UT code for WoS article
—
EID of the result in the Scopus database
—